Are People With Chronic Kidney Disease Being Excluded From Clinical Trials and Access to New Therapies?

Major European and international kidney associations have joined in an awareness campaign to stress the urgent need to include patients with chronic kidney disease in clinical trials. In a recent…

Continue Reading Are People With Chronic Kidney Disease Being Excluded From Clinical Trials and Access to New Therapies?

Patients with Amyotrophic Lateral Sclerosis Can Now Change the TV Channel with Just Their Eyes

For rare disease patients who face physical disabilities, even seemingly simple tasks can pose extreme difficulties. For instance, changing the channel on the television. Comcast Corp. previously created a voice…

Continue Reading Patients with Amyotrophic Lateral Sclerosis Can Now Change the TV Channel with Just Their Eyes

Study Determines More Research is Needed Regarding the Effect of Body Weight on Juvenile Idiopathic Arthritis

The Study Juvenile idiopathic arthritis (JIA) is a rare disease that causes inflammation in the joints. It is of unknown origin and has no cure. Previous investigations in studies with…

Continue Reading Study Determines More Research is Needed Regarding the Effect of Body Weight on Juvenile Idiopathic Arthritis
FDA Grants Fast Track Designation to Diffuse Large B-Cell Lymphoma Drug Candidate
https://pixabay.com/en/thumbs-up-okay-good-well-done-2056022/

FDA Grants Fast Track Designation to Diffuse Large B-Cell Lymphoma Drug Candidate

According to a press release from the New Jersey-based biotechnology company Cellectar Biosciences, the Food and Drug Administration (FDA) has granted "Fast Track" designation to the Company's experimental diffuse large…

Continue Reading FDA Grants Fast Track Designation to Diffuse Large B-Cell Lymphoma Drug Candidate
Avrobio’s Experimental Fabry Disease Gene Therapy Shows Promise in Early Trials
jarmoluk / Pixabay

Avrobio’s Experimental Fabry Disease Gene Therapy Shows Promise in Early Trials

According to a press release from the Massachusetts-based biotechnology company Avrobio, Inc., clinical tests of the Company's experimental Fabry disease gene therapy, AVR-RD-01, have yielded impressive preliminary results. Though the…

Continue Reading Avrobio’s Experimental Fabry Disease Gene Therapy Shows Promise in Early Trials